Plasma Lipidomics Profiling of Developmental Dysplasia of the Hip in Tibet Plateau
- PMID: 40241981
- PMCID: PMC11997466
- DOI: 10.1002/hcs2.70012
Plasma Lipidomics Profiling of Developmental Dysplasia of the Hip in Tibet Plateau
Abstract
Background: Developmental dysplasia of the hip (DDH) is a prevalent pediatric condition with a multifactorial etiology. Its incidence varies geographically, with notably higher rates observed on the Tibet plateau. This study was performed to evaluate the lipidomics signatures associated with DDH by analyzing plasma samples.
Methods: Fifty infants were recruited, including 25 diagnosed with DDH and 25 age-matched healthy controls. In addition to plasma samples, comprehensive laboratory test results and medical records were collected for each participant. An untargeted lipidomics profiling approach was employed to identify distinguishing metabolic signatures.
Results: Lipidomics profiles differed significantly between patients with DDH and healthy controls. Several differential metabolites were identified, including triacylglycerol (TAG)(17:0/18:1/20:1), TAG(17:0/17:0/17:0), phosphatidylethanolamine (PE)(10:0/26:4), TAG(17:0/18:0/18:0), TAG(16:0/17:0/22:1), TAG(16:0/18:0/22:0), TAG(17:0/19:0/19:0), TAG(13:0/20:0/20:0), TAG(18:0/18:0/22:0), and TAG(16:0/20:0/20:0). The primary lipid species showing differences were TAGs and PE.
Conclusions: Distinct shifts in lipidomics profiles were observed in infants with DDH. To the best of our knowledge, this study is the first to explore lipidomics signatures in patients with DDH. The combined assessment of TAG(17:0/18:1/20:1) and TAG(17:0/17:0/17:0) may serve as a potential diagnostic tool for DDH.
Keywords: developmental dysplasia of the hip; diagnosis; lipidomics; pediatric orthopedic; phosphatidylethanolamine; triacylglycerols.
© 2025 The Author(s). Health Care Science published by John Wiley & Sons, Ltd on behalf of Tsinghua University Press.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Plasma metabolomics signatures of developmental dysplasia of the hip in Tibet plateau.Orphanet J Rare Dis. 2024 Jun 8;19(1):228. doi: 10.1186/s13023-024-03230-w. Orphanet J Rare Dis. 2024. PMID: 38851765 Free PMC article.
-
Screening for Developmental Dysplasia of the Hip in Infants in Tibet Identifies Increased Prevalence Associated with Altitude.Med Sci Monit. 2019 Aug 3;25:5771-5775. doi: 10.12659/MSM.916456. Med Sci Monit. 2019. PMID: 31376279 Free PMC article.
-
Seminal Plasma Lipidomics Profiling to Identify Signatures of Kallmann Syndrome.Front Endocrinol (Lausanne). 2021 Jul 29;12:692690. doi: 10.3389/fendo.2021.692690. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34393999 Free PMC article.
-
Cochrane Review: Screening programmes for developmental dysplasia of the hip in newborn infants.Evid Based Child Health. 2013 Jan;8(1):11-54. doi: 10.1002/ebch.1891. Evid Based Child Health. 2013. PMID: 23878122 Review.
-
Evaluation and Referral for Developmental Dysplasia of the Hip in Infants.Pediatrics. 2016 Dec;138(6):e20163107. doi: 10.1542/peds.2016-3107. Epub 2016 Nov 21. Pediatrics. 2016. PMID: 27940740 Review.
References
-
- Agostiniani R., Atti G., Bonforte S., et al., “Recommendations for Early Diagnosis of Developmental Dysplasia of the Hip (DDH): Working Group Intersociety Consensus Document, Italian Journal of Pediatrics,” Italian Journal of Pediatrics 46, no. 1 (2020): 150, 10.1186/s13052-020-00908-2. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials